Crypto Market Cap, BTC/USD, ETH/USD, USDT/USD, XRP/USD, Bitcoin
Apple, Advanced Micro Devices Inc, Amazon Com Inc, TESLA INC, NETFLIX INC, Facebook Inc
S&P 500, Nasdaq 100, Dow 30, Russell 2000, U.S. Dollar Index, Bitcoin Index
US 10Y, Euro Bund, Germany 10Y, Japan 10Y Yield, UK 10Y, India 10Y
Fresenius Medical Care is the largest dialysis company in the world, treating about 345,000 patients in roughly 4,000 clinics across the globe as of December 2019. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis...
This is a stock in healthcare and is in the dialysis field. It appears they missed earnings or gave grim guidance. Dialysis is grim, take my word for it )o: Located in Germany but the clinics are in the US, and not a lot of competition. DVA is one that I know of. Extremely oversold.. There has been extreme selling pressure indicated by being below the...
Earnings were 7-30 Has broken from cup and handle pattern. No rising wedges noted I was looking for something "safe" for my IRA. I know in the market nothing is really safe, but this is a dialysis company. Dialysis is not going away and my first job as a nurse was in a dialysis clinic. Buffet says stay with stuff you know (o: Fresenius Medical Care AG & Co....
Fresenius Medical upgraded to Buy from Hold at Jefferies. Jefferies analyst James Vane-Tempest upgraded Fresenius Medical Care to Buy from Hold with a $44.50 price target. The company's homecare strategy is being underestimated by the market and the roll out of NxStage dialysis products could drive shareholder value, Vane-Tempest tells investors in a research...